Mega Lifesciences PCL (BKK:MEGA)

Market Cap	30.30B +28.7%
Revenue (ttm)	14.63B -1.6%
Net Income	2.07B +4.1%
EPS	2.36 +3.8%
Shares Out	871.87M
PE Ratio	14.71
Forward PE	12.98
Dividend	1.60 (4.60%)
Ex-Dividend Date	Mar 9, 2026

Volume	344,727
Average Volume	847,031
Open	34.75
Previous Close	34.75
Day's Range	34.75 - 35.50
52-Week Range	24.30 - 40.00
Beta	0.33
RSI	50.89
Earnings Date	May 14, 2026

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. The company operates through three segments: Brands, Distribution, and Original Equipment Manufacture. It offers wellness and nutrition products, including medical and sports nutrition, general well-being, vitamins, probiotics, herbal medicines, and cough and cold medicines, as well as hair, kid’s, men’...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2025, Mega Lifesciences PCL's revenue was 14.19 billion, a decrease of -7.74% compared to the previous year's 15.39 billion. Earnings were 1.91 billion, a decrease of -4.99%.